Stay updated on Semaglutide Effectiveness in Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.

Latest updates to the Semaglutide Effectiveness in Obesity Clinical Trial page
- CheckyesterdayChange DetectedIsrael site list updated: Qiryat Krinitzi, Israel, 52621 added; Tel Litwinsky, Israel, 52621 removed. Revision: v3.6.6 updated from v3.6.5.SummaryDifference0.1%

- Check8 days agoChange DetectedA new NIH funding line was added to the study's external identifiers, indicating U.S. NIH support for the trial.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedRevision: v3.6.5 has been added, replacing the previous Revision: v3.6.4. This appears to be a minor site/version update reflected in the page footer and does not change the study details shown on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedThe study page now shows Revision: v3.6.4, replacing the previous Revision: v3.6.3, indicating an update to the study record metadata. This update appears to be administrative and does not modify user-facing content such as eligibility criteria or results.SummaryDifference0.0%

- Check59 days agoChange DetectedThe study record revision updated from v3.6.2 to v3.6.3, indicating a new version of the record. This reflects an administrative update rather than changes to study data or eligibility.SummaryDifference0.0%

- Check66 days agoChange DetectedA new publication citation is added to the Publications section, referring to the 2024 Diabetes Obes Metab paper by Rubino et al. The page revision was updated to v3.6.2, and the previous revision note v3.6.0 was removed.SummaryDifference0.1%

Stay in the know with updates to Semaglutide Effectiveness in Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Effectiveness in Obesity Clinical Trial page.